Search results for: Dog
#33080490 2020/09/22 To Up
Periprocedural vascular access complications associated with percutaneous femoral arterial access using the modified Seldinger's technique in dogs during cardiac catheterization: a single-center experience.The primary objective of this study is to evaluate the peri-procedural major and minor complications associated with percutaneous femoral arterial access using modified Seldinger's technique in dogs that underwent cardiac catheterization.
D J Stern, T Gunasekaran, R A Sanders
2188 related Products with: Periprocedural vascular access complications associated with percutaneous femoral arterial access using the modified Seldinger's technique in dogs during cardiac catheterization: a single-center experience.1150 ug50 ug50 ug250 ml50 ug1
#33080489 2020/09/19 To Up
Acute effects of intravenous pimobendan administration in dog models of chronic precapillary pulmonary hypertension.Pulmonary hypertension (PH) is a progressive and potentially life-threatening disease. Several drugs are used for the treatment of dogs with precapillary PH. Pimobendan is an inotropic drug with phosphodiesterase 3 inhibitory and calcium-sensitizing effects. Pimobendan administration improved right ventricular (RV) function and lowered pulmonary arterial pressure in some human patients with precapillary PH. However, the efficacy of pimobendan in dogs with precapillary PH is unknown.
T Morita, K Nakamura, T Osuga, S Kawamoto, S Miki, K Sasaoka, M Takiguchi
1606 related Products with: Acute effects of intravenous pimobendan administration in dog models of chronic precapillary pulmonary hypertension.5 G 50 UG50ug25 mg100ug100ug Lyophilized1 Set1 Set4 Arrays/Slide1 Set1 Set
#33079588 2020/10/20 To Up
Letter by Simonato and Altmayer Regarding Article, "Dog Ownership and Survival: A Systematic Review and Meta-Analysis".
Matheus Simonato, Stephan Altmayer
1974 related Products with: Letter by Simonato and Altmayer Regarding Article, "Dog Ownership and Survival: A Systematic Review and Meta-Analysis".200ul10 mg100 mg100ul25 mg100 mg50 ug 25 MG100ug10 mg5mg
No related Items
#33079587 2020/10/20 To Up
Response by Kramer et al to Letters Regarding Article, "Dog Ownership and Survival: A Systematic Review and Meta-Analysis".
Caroline K Kramer, Sadia Mehmood, Renée S Suen
2178 related Products with: Response by Kramer et al to Letters Regarding Article, "Dog Ownership and Survival: A Systematic Review and Meta-Analysis".5 G1 module1 module1 module1 module 25 G500 mg51 module25 mg1 module
No related Items
#33079586 2020/10/20 To Up
Letter by Owen et al Regarding Article, "Dog Ownership and Survival: A Systematic Review and Meta-Analysis".
Katherine B Owen, Adrian Bauman, Magnhild Oust Torske
1290 related Products with: Letter by Owen et al Regarding Article, "Dog Ownership and Survival: A Systematic Review and Meta-Analysis".5 G1,000 tests1 mg100 mg100ug1 ml2.5 mg25 mg1000 tests200ug 5 G
No related Items
#33079585 2020/10/20 To Up
Does Dog Ownership Really Prolong Survival?: A Revised Meta-Analysis and Reappraisal of the Evidence.
Adrian Bauman, Katherine B Owen, Magnhild Oust Torske, Ding Ding, Steinar Krokstad, Emmanuel Stamatakis
2393 related Products with: Does Dog Ownership Really Prolong Survival?: A Revised Meta-Analysis and Reappraisal of the Evidence.15 ml 1 module1 module10 mg1 ml1 module1000 tests100ug1 module1 module
No related Items
#33079268 2020/10/20 To Up
Usual or unusual presentations of Dirofilaria repens in two sibling dogs: a case report.T
Giulia Barlozzari, Tiziana Felice, Laura Salvato, Raffaella Conti, Claudio De Liberato, Federica Furzi, Simona Gabrielli, Manuela Scarpulla
1283 related Products with: Usual or unusual presentations of Dirofilaria repens in two sibling dogs: a case report.
No related Items
#33078965 2020/10/20 To Up
Preclinical and pharmacokinetic properties of danicamtiv, a new targeted myosin activator for the treatment of dilated cardiomyopathy.Dilated cardiomyopathy (DCM) is a disease of the myocardium defined by left ventricular enlargement and systolic dysfunction leading to heart failure. Danicamtiv, a new targeted myosin activator designed for the treatment of DCM, was characterized in and preclinical studies. Danicamtiv human hepatic clearance was predicted to be 0.5 mL/min/kg from metabolic stability studies in human hepatocytes. For human, plasma protein binding was moderate with a fraction unbound of 0.16, whole blood-to-plasma partitioning ratio was 0.8, and danicamtiv showed high permeability and no efflux in a Caco-2 cell line. Danicamtiv metabolism pathways included CYP-mediated amide-cleavage, -demethylation, as well as isoxazole- and piperidine-ring-opening. Danicamtiv clearance was low across species with 15.5, 15.3, 1.6, and 5.7 mL/min/kg in mouse, rat, dog, and monkey, respectively. Volume of distribution ranged from 0.24 L/kg in mouse to 1.7 L/kg in rat. Oral bioavailability ranged from 26% in mouse to 108% in dog. Simple allometric scaling prediction of human plasma clearance, volume of distribution, and half-life was 0.64 mL/min/kg, 0.98 L/kg, and 17.7 h, respectively. Danicamtiv preclinical attributes and predicted human pharmacokinetics supported advancement toward clinical development.
Mark P Grillo, Svetlana Markova, Marc Evanchik, Marc Trellu, Patricia Moliner, Priscilla Brun, Anne Perreard-Dumaine, Pascale Vicat, Jim Driscoll, Tim J Carlson
1444 related Products with: Preclinical and pharmacokinetic properties of danicamtiv, a new targeted myosin activator for the treatment of dilated cardiomyopathy.1000 TESTS/0.65ml100 mg50 ug 0.1 mg10 mg100ul0.2 mg100.00 ul500 mg 100ul
#33078825 2020/10/20 To Up
Machine learning application identifies novel gene signatures from transcriptomic data of spontaneous canine hemangiosarcoma.Angiosarcomas are soft-tissue sarcomas that form malignant vascular tissues. Angiosarcomas are very rare, and due to their aggressive behavior and high metastatic propensity, they have poor clinical outcomes. Hemangiosarcomas commonly occur in domestic dogs, and share pathological and clinical features with human angiosarcomas. Typical pathognomonic features of this tumor are irregular vascular channels that are filled with blood and are lined by a mixture of malignant and nonmalignant endothelial cells. The current gold standard is the histological diagnosis of angiosarcoma; however, microscopic evaluation may be complicated, particularly when tumor cells are undetectable due to the presence of excessive amounts of nontumor cells or when tissue specimens have insufficient tumor content. In this study, we implemented machine learning applications from next-generation transcriptomic data of canine hemangiosarcoma tumor samples (n = 76) and nonmalignant tissues (n = 10) to evaluate their training performance for diagnostic utility. The 10-fold cross-validation test and multiple feature selection methods were applied. We found that extra trees and random forest learning models were the best classifiers for hemangiosarcoma in our testing datasets. We also identified novel gene signatures using the mutual information and Monte Carlo feature selection method. The extra trees model revealed high classification accuracy for hemangiosarcoma in validation sets. We demonstrate that high-throughput sequencing data of canine hemangiosarcoma are trainable for machine learning applications. Furthermore, our approach enables us to identify novel gene signatures as reliable determinants of hemangiosarcoma, providing significant insights into the development of potential applications for this vascular malignancy.
Nuojin Cheng, Ashley J Schulte, Fadil Santosa, Jong Hyuk Kim
1172 related Products with: Machine learning application identifies novel gene signatures from transcriptomic data of spontaneous canine hemangiosarcoma.0.25 mg100ug Lyophilized100ug Lyophilized100ug Lyophilized50ul 100ul100ug Lyophilized 100ul100 ml 100ul0.2ml
#33078734 // To Up
Change in jaw occlusive power by paralysis of masseter muscle with a neuromuscular blocker: Sion's masseter muscle paralysis.We aimed to determine whether jaw occlusive power decreases with the injection of neuromuscular blocking agents in masseter muscle - a method we named Sion's masseter muscle paralysis (SMP).
Sion Jo, Jae Baek Lee, Youngho Jin, Taeoh Jeong, Jae Chol Yoon, Boyoung Park
2617 related Products with: Change in jaw occlusive power by paralysis of masseter muscle with a neuromuscular blocker: Sion's masseter muscle paralysis.100ul 6 ml Ready-to-use 100ug Lyophilized200ul 2 ml Ready-to-use 900 tests200ul100ul100 μg1 ml
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45 Fax 0032 16 50 90 45
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50 Fax 01 43 25 01 60
52062 Aachen Deutschland
Tel 0241 40 08 90 86 Fax 0241 55 91 05 36
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
Schweiz Züri +41435006251
Česká republika Praha +420246019719
Ireland Dublin +35316526556
Norge Oslo +4721031366
Finland Helsset +358942419041
Sverige Stockholm +46852503438
Ελλάς Αθήνα +302111768494
Magyarország Budapest +3619980547
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
GENTAUR Nederland BV
5521 DG Eersel Nederland
Tel 0208-080893 Fax 0497-517897
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93 Fax 02 36 00 65 94
53 Iskar Str. 1191 Kokalyane, Sofia